Search research articles
Contact Us
Filters
Showing results (81-90 of 111) with videos related to
Page
of 12
Sort By:
Gut
|
June 9, 2012
Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions
Albrecht Neesse, Anke Hahnenkamp, Heidi Griesmann, et al.
Ebiomedicine
|
October 11, 2019
SPARC dependent collagen deposition and gemcitabine delivery in a genetically engineered mouse model of pancreas cancer
Iswarya Ramu, Sören M Buchholz, Melanie S Patzak, et al.
Case Reports in Gastroenterology
|
March 30, 2022
Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab
Sebastian Schade, Ute Koenig, Ardian Mekolli, et al.
Gastroenterology
|
June 19, 2016
ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer
Steffen Heeg, Koushik K Das, Maximilian Reichert, et al.
Journal of Personalized Medicine
|
December 23, 2023
Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology
Soeren M Buchholz, Nelia Nause, Ute König, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
February 9, 2023
NFATc1 Is a Central Mediator of EGFR-Induced ARID1A Chromatin Dissociation During Acinar Cell Reprogramming
Zhe Zhang, Xin Wang, Feda H Hamdan, et al.
Msystems
|
August 24, 2021
Comprehensive Wet-Bench and Bioinformatics Workflow for Complex Microbiota Using Oxford Nanopore Technologies
Christoph Ammer-Herrmenau, Nina Pfisterer, Tim van den Berg, et al.
Ebiomedicine
|
February 3, 2019
Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites
Melanie S Patzak, Vijayalakshmi Kari, Shilpa Patil, et al.
Molecular Cancer Therapeutics
|
January 30, 2016
GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
Sandra Baumgart, Nai-Ming Chen, Jin-San Zhang, et al.
Gut
|
April 2, 2022
NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression
Muhammad Umair Latif, Geske Elisabeth Schmidt, Sercan Mercan, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 111) with videos related to
Sort By:
Page
of 12
Gut
|
June 9, 2012
Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions
Albrecht Neesse, Anke Hahnenkamp, Heidi Griesmann, et al.
Ebiomedicine
|
October 11, 2019
SPARC dependent collagen deposition and gemcitabine delivery in a genetically engineered mouse model of pancreas cancer
Iswarya Ramu, Sören M Buchholz, Melanie S Patzak, et al.
Case Reports in Gastroenterology
|
March 30, 2022
Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab
Sebastian Schade, Ute Koenig, Ardian Mekolli, et al.
Gastroenterology
|
June 19, 2016
ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer
Steffen Heeg, Koushik K Das, Maximilian Reichert, et al.
Journal of Personalized Medicine
|
December 23, 2023
Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology
Soeren M Buchholz, Nelia Nause, Ute König, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
February 9, 2023
NFATc1 Is a Central Mediator of EGFR-Induced ARID1A Chromatin Dissociation During Acinar Cell Reprogramming
Zhe Zhang, Xin Wang, Feda H Hamdan, et al.
Msystems
|
August 24, 2021
Comprehensive Wet-Bench and Bioinformatics Workflow for Complex Microbiota Using Oxford Nanopore Technologies
Christoph Ammer-Herrmenau, Nina Pfisterer, Tim van den Berg, et al.
Ebiomedicine
|
February 3, 2019
Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites
Melanie S Patzak, Vijayalakshmi Kari, Shilpa Patil, et al.
Molecular Cancer Therapeutics
|
January 30, 2016
GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
Sandra Baumgart, Nai-Ming Chen, Jin-San Zhang, et al.
Gut
|
April 2, 2022
NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression
Muhammad Umair Latif, Geske Elisabeth Schmidt, Sercan Mercan, et al.
Page
of 12